These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 30009261)

  • 41. Dysregulated interleukin-23 signalling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression.
    Nakayama W; Jinnin M; Tomizawa Y; Nakamura K; Kudo H; Inoue K; Makino K; Honda N; Kajihara I; Fukushima S; Ihn H
    Rheumatology (Oxford); 2017 Jan; 56(1):145-155. PubMed ID: 27744356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. STAT6 suppression prevents bleomycin-induced dermal fibrosis.
    Huang J; Puente H; Wareing NE; Wu M; Mayes MD; Karmouty-Quintana H; Assassi S; Mills TW
    FASEB J; 2023 Feb; 37(2):e22761. PubMed ID: 36629780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
    Quan S; Sheng JR; Abraham PM; Soliven B
    Clin Exp Immunol; 2016 Apr; 184(1):50-61. PubMed ID: 26671281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells.
    Yoshizaki A; Taniguchi T; Saigusa R; Fukasawa T; Ebata S; Numajiri H; Nakamura K; Yamashita T; Takahashi T; Toyama T; Asano Y; Tedder TF; Sato S
    Ann Rheum Dis; 2016 Oct; 75(10):1858-65. PubMed ID: 26567180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-30c attenuates fibrosis progression and vascular dysfunction in systemic sclerosis model mice.
    Kanno Y; Shu E; Niwa H; Seishima M; Ozaki KI
    Mol Biol Rep; 2021 Apr; 48(4):3431-3437. PubMed ID: 33913094
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.
    Yoshizaki A; Yanaba K; Yoshizaki A; Iwata Y; Komura K; Ogawa F; Takenaka M; Shimizu K; Asano Y; Hasegawa M; Fujimoto M; Sato S
    Arthritis Rheum; 2010 Aug; 62(8):2476-87. PubMed ID: 20506342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis.
    Grönberg C; Rattik S; Tran-Manh C; Zhou X; Rius Rigau A; Li YN; Györfi AH; Dickel N; Kunz M; Kreuter A; Matei EA; Zhu H; Skoog P; Liberg D; Distler JH; Trinh-Minh T
    Ann Rheum Dis; 2024 Aug; 83(9):1156-1168. PubMed ID: 38594058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice.
    Taniguchi T; Asano Y; Akamata K; Noda S; Takahashi T; Ichimura Y; Toyama T; Trojanowska M; Sato S
    Arthritis Rheumatol; 2015 Feb; 67(2):517-26. PubMed ID: 25385187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
    Brkic Z; van Bon L; Cossu M; van Helden-Meeuwsen CG; Vonk MC; Knaapen H; van den Berg W; Dalm VA; Van Daele PL; Severino A; Maria NI; Guillen S; Dik WA; Beretta L; Versnel MA; Radstake T
    Ann Rheum Dis; 2016 Aug; 75(8):1567-73. PubMed ID: 26371289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
    Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis.
    Avouac J; Fürnrohr BG; Tomcik M; Palumbo K; Zerr P; Horn A; Dees C; Akhmetshina A; Beyer C; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheum; 2011 Mar; 63(3):800-9. PubMed ID: 21360510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis.
    Zhang L; Zheng D; Yan Y; Yu Y; Chen R; Li Z; Greer PA; Peng T; Wang Q
    Arthritis Res Ther; 2022 Jun; 24(1):148. PubMed ID: 35729674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-33/ST2 axis contributes to the dermal fibrosis of systemic sclerosis via promoting fibroblasts activation.
    Wu X; Ming B; Wu T; Gao R; Hu P; Tang J; Zhong J; Zheng F; Dong L
    J Dermatol Sci; 2022 Aug; 107(2):95-104. PubMed ID: 35940987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-21a-5p inhibition alleviates systemic sclerosis by targeting STAT3 signaling.
    Park JS; Kim C; Choi J; Jeong HY; Moon YM; Kang H; Lee EK; Cho ML; Park SH
    J Transl Med; 2024 Apr; 22(1):323. PubMed ID: 38561750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RGC32 Promotes Bleomycin-Induced Systemic Sclerosis in a Murine Disease Model by Modulating Classically Activated Macrophage Function.
    Sun C; Chen SY
    J Immunol; 2018 Apr; 200(8):2777-2785. PubMed ID: 29507108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.
    Huarte E; Jun S; Rynda-Apple A; Golden S; Jackiw L; Hoffman C; Maddaloni M; Pascual DW
    J Immunol; 2016 Jun; 196(12):5036-46. PubMed ID: 27194787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathogenic roles of B lymphocytes in systemic sclerosis.
    Yoshizaki A
    Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered B lymphocyte homeostasis and functions in systemic sclerosis.
    Forestier A; Guerrier T; Jouvray M; Giovannelli J; Lefèvre G; Sobanski V; Hauspie C; Hachulla E; Hatron PY; Zéphir H; Vermersch P; Labalette M; Launay D; Dubucquoi S
    Autoimmun Rev; 2018 Mar; 17(3):244-255. PubMed ID: 29343447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.